RU2004133532A - Фармацевтические препараты с замедленным высвобождением и способы их получения - Google Patents

Фармацевтические препараты с замедленным высвобождением и способы их получения Download PDF

Info

Publication number
RU2004133532A
RU2004133532A RU2004133532/15A RU2004133532A RU2004133532A RU 2004133532 A RU2004133532 A RU 2004133532A RU 2004133532/15 A RU2004133532/15 A RU 2004133532/15A RU 2004133532 A RU2004133532 A RU 2004133532A RU 2004133532 A RU2004133532 A RU 2004133532A
Authority
RU
Russia
Prior art keywords
sustained release
albuterol
hour
release tablet
composition
Prior art date
Application number
RU2004133532/15A
Other languages
English (en)
Russian (ru)
Inventor
Даведжибхан КУМБХАНИ (US)
Даведжибхан КУМБХАНИ
Хариш Б ПАНДИЯ (US)
Хариш Б ПАНДИЯ
Хирен ПАТЕЛ (US)
Хирен ПАТЕЛ
Original Assignee
Плива, Инк. (Us)
Плива, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Плива, Инк. (Us), Плива, Инк. filed Critical Плива, Инк. (Us)
Publication of RU2004133532A publication Critical patent/RU2004133532A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
RU2004133532/15A 2002-04-12 2003-04-11 Фармацевтические препараты с замедленным высвобождением и способы их получения RU2004133532A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/120,501 US7125563B2 (en) 2002-04-12 2002-04-12 Sustained release pharmaceutical preparations and methods for producing the same
US10/120,501 2002-04-12

Publications (1)

Publication Number Publication Date
RU2004133532A true RU2004133532A (ru) 2005-06-10

Family

ID=29214431

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004133532/15A RU2004133532A (ru) 2002-04-12 2003-04-11 Фармацевтические препараты с замедленным высвобождением и способы их получения

Country Status (10)

Country Link
US (3) US7125563B2 (enExample)
EP (1) EP1494653A1 (enExample)
JP (1) JP2005532289A (enExample)
CN (1) CN1655765A (enExample)
AU (1) AU2003218397A1 (enExample)
CA (1) CA2481667A1 (enExample)
HR (1) HRP20040945A2 (enExample)
PL (1) PL373328A1 (enExample)
RU (1) RU2004133532A (enExample)
WO (1) WO2003086364A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
ATE341312T1 (de) * 2003-05-20 2006-10-15 Ethypharm Sa Orale pharmazeutische zusammensetzung mit verzögerter freisetzung
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
EP2018160B1 (en) 2006-03-16 2011-12-14 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
WO2007112581A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2296634A1 (en) * 2008-06-02 2011-03-23 Dexcel Pharma Technologies Ltd. Process for manufacture of a medicament with granulation and pan coating
WO2011102504A1 (ja) 2010-02-22 2011-08-25 第一三共株式会社 経口用徐放性固形製剤
EP2540294B1 (en) * 2010-02-22 2016-08-03 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
KR102127625B1 (ko) 2012-09-03 2020-06-29 다이이찌 산쿄 가부시키가이샤 하이드로모르폰염산염 함유의 경구용 서방성 의약 조성물
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
CR20190142A (es) * 2016-09-07 2019-05-22 Saniona As Composiciones de tesofensina
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264573A (en) 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4503030A (en) 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
US4587117A (en) 1983-06-06 1986-05-06 Alza Corporation Medical device for delivering drug to pH environments greater than 3.5
US4851229A (en) 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent
US4751071A (en) 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
US4777049A (en) 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
IT1213080B (it) * 1986-06-17 1989-12-07 Recordati Chem Pharm Sistemi terapeutico per la cessione controllata di farmaci.
US5254347A (en) 1988-03-31 1993-10-19 Tanabe Seiyaku Co., Ltd. Controlled release pharmaceutical preparation and method for producing the same
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
IL92966A (en) 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5248516A (en) * 1989-12-19 1993-09-28 Fmc Corporation Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
US5075115A (en) * 1990-04-02 1991-12-24 Fmc Corporation Process for polymerizing poly(lactic acid)
IE61651B1 (en) 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
ATE192335T1 (de) 1990-12-20 2000-05-15 Warner Jenkinson Co Inc Filmbildende zusammensetzungen aus feuchtem pulver
JPH04235914A (ja) * 1991-01-18 1992-08-25 Kyowa Hakko Kogyo Co Ltd 徐放性製剤
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
ATE133331T1 (de) * 1991-11-13 1996-02-15 Glaxo Canada Vorrichtung zur kontrollierten wirkstoffreigabe
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5543154A (en) 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
JP2665858B2 (ja) * 1992-05-30 1997-10-22 日本ヘキスト・マリオン・ルセル株式会社 持効性塩酸オキシブチニン製剤
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
SK279684B6 (sk) 1993-06-14 1999-02-11 Janssen Pharmaceutica N.V. Tableta a spôsob jej výroby
US5472714A (en) 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US6210714B1 (en) 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
US5500227A (en) 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5464633A (en) 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
SE9402431D0 (sv) 1994-07-08 1994-07-08 Astra Ab New tablet formulation
WO1996019974A1 (en) 1994-12-27 1996-07-04 Kanebo, Ltd. Sustained-release preparation
IL116674A (en) 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US6262115B1 (en) 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6124355A (en) 1995-05-22 2000-09-26 Guittard; George V. Oxybutynin therapy
US5674895A (en) 1995-05-22 1997-10-07 Alza Corporation Dosage form comprising oxybutynin
US5912268A (en) 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US5945124A (en) 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
SE9600072D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
US6245351B1 (en) 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
FR2752162B1 (fr) * 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
US5780055A (en) 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension
US5807580A (en) 1996-10-30 1998-09-15 Mcneil-Ppc, Inc. Film coated tablet compositions having enhanced disintegration characteristics
US5837379A (en) 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5751524A (en) * 1997-03-10 1998-05-12 Square D Company Ground fault protection circuit for a multiple source system
US6210710B1 (en) 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
DE59804823D1 (de) * 1997-09-25 2002-08-22 Bayer Ag Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
TW477702B (en) 1997-10-23 2002-03-01 Dev Center Biotechnology Controlled release tacrine dosage form
US6156347A (en) 1998-01-21 2000-12-05 Bio-Dar Ltd. Controlled release chromium picolinate
US6251430B1 (en) 1998-02-04 2001-06-26 Guohua Zhang Water insoluble polymer based sustained release formulation

Also Published As

Publication number Publication date
US20080107730A1 (en) 2008-05-08
CA2481667A1 (en) 2003-10-23
AU2003218397A1 (en) 2003-10-27
US20060105037A1 (en) 2006-05-18
EP1494653A1 (en) 2005-01-12
WO2003086364A1 (en) 2003-10-23
PL373328A1 (en) 2005-08-22
CN1655765A (zh) 2005-08-17
JP2005532289A (ja) 2005-10-27
US20030198670A1 (en) 2003-10-23
US7125563B2 (en) 2006-10-24
HRP20040945A2 (en) 2005-02-28

Similar Documents

Publication Publication Date Title
RU2004133532A (ru) Фармацевтические препараты с замедленным высвобождением и способы их получения
RU2141822C1 (ru) Новые гранулы для регулируемого высвобождения и фармацевтические препараты, содержащие такие гранулы
US4966768A (en) Sustained release etodolac
CA1339072C (en) Pharmaceutical formulation as well as a process for its preparation
ES2204193T3 (es) Nueva perla de liberacion controlada, un metodo para su produccion y formulacion de multiples unidades que la contiene.
US5807579A (en) Pseudoephedrine combination pharmaceutical compositions
US6703044B1 (en) Venlafaxine formulations
CA1147651A (en) Sustained release pharmaceutical compositions
NO20161918A1 (no) Preparater for transdermal oksybutyninterapi
KR950007854A (ko) 이중층 옥스카바제핀 정제
KR880001288A (ko) 경구투여 형태의 서방성 약제학적 조성물
WO1993009767A1 (fr) Formulation a base de diltiazem a liberation prolongee
KR920702618A (ko) 약제학적 제형
KR100548925B1 (ko) 약물의 경구투여용 서방성 조성물
ES2238982T3 (es) Formulacion de carbamazepina de liberacion prolongada.
EP1633329A1 (en) Modified release formulations of selective serotonin re-uptake inhibitors
US20070082049A1 (en) Extended release venlafaxine tablet formulation
EP0906101B1 (fr) Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine
CN101642443B (zh) 单硝酸异山梨酯渗透泵型控释制剂及其制备方法
US4411882A (en) Galenical compositions
CN106943368A (zh) 米氮平片剂及其制备方法
US20060246132A1 (en) Sustained release formulations of venlafaxine
CA2433915A1 (en) Improved controlled release oral dosage form
KR20210012082A (ko) 미라베그론 및 탐스로신을 포함하는 약학 조성물
CN103860514B (zh) 一种盐酸奥昔布宁渗透泵控释片及其制备方法

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20070920